Results 121 to 130 of about 161,535 (242)

Protective Immunity Induced by DNA Vaccines Encoding TgGRA47 and TgGRA72 Against <i>Toxoplasma gondii</i> Infection in BALB/c Mice. [PDF]

Transbound Emerg Dis
Zhou Z, Mu J, Sun J, Chen J, Zhou C.
europepmc   +1 more source

Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer. [PDF]

Vaccines (Basel)
Moseman JE, Shim D, Jeon D, Rastogi I, Schneider KM, McNeel DG.   +5 more
europepmc   +1 more source

APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response. [PDF]

Cancer Immunol Immunother
Barrio-Calvo M, Friis S, Kofoed SV, Holste SC, Andersen RO, Rønø B, Hjortø GM.   +6 more
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

Angewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Plasmid DNA vaccines encapsulated in lipid nanoparticles elicit STING-dependent type 1 interferon release. [PDF]

Mol Ther Adv
Moseman JE, Brinkman HM, Choe JA, Shim D, Burger JC, Ferraresso F, Rastogi I, Kastrup CJ, Murphy WL, McNeel DG.   +9 more
europepmc   +1 more source

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants. [PDF]

PLoS One, 2023
Kim SE, Park SH, Park WJ, Kim G, Kim SY, Won H, Hwang YH, Lim H, Kim HG, Kim YJ, Kim D, Lee JA.   +11 more
europepmc   +1 more source

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). [PDF]

J Immunother Cancer
Kyriakopoulos CE, Pachynski RK, Eickhoff JC, Tonelli TP, Jeon D, McNeel DG.   +5 more
europepmc   +1 more source

Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses. [PDF]

JCI Insight, 2023
van Bergen J, Camps MG, Pardieck IN, Veerkamp D, Leung WY, Leijs AA, Myeni SK, Kikkert M, Arens R, Zondag GC, Ossendorp F.   +10 more
europepmc   +1 more source

Circular Photocaged mRNA for Light‐induced Late‐stage Activation of Translation

Angewandte Chemie International Edition, EarlyView.
A clickable photo‐caged 5′ cap (CyCliCap) allows to make Cyclic Click Cap‐containing mRNA (CyCliCap‐mRNA) which is remarkably stable and translationally muted until irradiated, allowing for late‐stage activation of translation in cells by light. ABSTRACT mRNA is a new medical modality as vaccine and raises hopes to become a protein replacement agent ...
Bayram Terzi, Greta Charlotte Dahm, Kristoffer Heintz, Martin Sumser, Yasuaki Kimura, Hiroshi Abe, Andrea Rentmeister   +6 more
wiley   +1 more source

DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations. [PDF]

Int J Mol Sci
Neeli P, Chai D, Roy D, Prajapati S, Bonam SR.   +4 more
europepmc   +1 more source